线粒体作为治疗靶点。
Mitochondria as a target in treatment.
机构信息
Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
出版信息
Environ Mol Mutagen. 2010 Jun;51(5):462-75. doi: 10.1002/em.20554.
Abstract
Mitochondria are key organelles that perform essential cellular functions and play pivotal roles in cell death and survival signaling. Hence, they represent an attractive target for drugs to treat metabolic, degenerative, and hyperproliferative diseases. Targeting mitochondria with organelle-specific agents or prodrugs has proven to be an effective therapeutic strategy. More specifically, controlling the cellular ROS balance via selective delivery of an antioxidant "payload" into mitochondria is an elegant emerging therapeutic concept. Herein, we review the recent medicinal chemistry and clinical data of these exploratory strategies, which should point the way for future generations of therapeutics.
摘要
线粒体是执行重要细胞功能并在细胞死亡和存活信号中发挥关键作用的关键细胞器。因此，它们代表了治疗代谢、退行性和过度增殖性疾病的药物的有吸引力的靶点。使用细胞器特异性试剂或前药靶向线粒体已被证明是一种有效的治疗策略。更具体地说，通过选择性地将抗氧化剂“有效载荷”递送到线粒体中来控制细胞内 ROS 平衡是一种优雅的新兴治疗概念。本文综述了这些探索性策略的最新药物化学和临床数据，这些数据应该为下一代治疗药物指明方向。
相似文献
1
Mitochondria as a target in treatment.线粒体作为治疗靶点。
Environ Mol Mutagen. 2010 Jun;51(5):462-75. doi: 10.1002/em.20554.
2
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成：药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
3
Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants.短杆菌肽 - TEMPO缀合物：新型线粒体靶向抗氧化剂。
Crit Care Med. 2007 Sep;35(9 Suppl):S461-7. doi: 10.1097/01.CCM.0000279192.96303.E7.
4
Targeting mitochondria.靶向线粒体
Acc Chem Res. 2008 Jan;41(1):87-97. doi: 10.1021/ar700135m.
5
Targeting antioxidants to mitochondria by conjugation to lipophilic cations.通过与亲脂性阳离子结合将抗氧化剂靶向输送至线粒体。
Annu Rev Pharmacol Toxicol. 2007;47:629-56. doi: 10.1146/annurev.pharmtox.47.120505.105110.
6
N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.N-乙酰半胱氨酸和维生素 E 可挽救线粒体复合物 I 疾病临床前模型中的动物寿命和细胞氧化应激。
Mol Genet Metab. 2018 Apr;123(4):449-462. doi: 10.1016/j.ymgme.2018.02.013. Epub 2018 Feb 23.
7
Antioxidant modulation in restoring mitochondrial function in neurodegeneration.抗氧化调节在恢复神经退行性变中的线粒体功能方面的作用
Int J Neurosci. 2017 Mar;127(3):218-235. doi: 10.1080/00207454.2016.1178261. Epub 2016 May 10.
8
Nanozymes targeting mitochondrial repair in disease treatment.靶向线粒体修复的纳米酶在疾病治疗中的应用。
J Biotechnol. 2024 Nov 10;394:57-72. doi: 10.1016/j.jbiotec.2024.08.008. Epub 2024 Aug 17.
9
Targeting antioxidants to mitochondria and cardiovascular diseases: the effects of mitoquinone.将抗氧化剂靶向作用于线粒体与心血管疾病：米托醌的作用
Med Sci Monit. 2007 Jul;13(7):RA132-45.
10
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.线粒体在药物毒理学中的作用：对一个古老且新出现的主题的重新评估。
Am J Physiol Cell Physiol. 2007 Jul;293(1):C12-21. doi: 10.1152/ajpcell.00314.2006. Epub 2007 May 2.
引用本文的文献
1
The future role of mitochondrial drugs in vascularized composite allotransplantation: A short review.线粒体药物在血管化复合组织异体移植中的未来作用：简要综述。
Cell Transplant. 2025 Jan-Dec;34:9636897251347749. doi: 10.1177/09636897251347749. Epub 2025 Aug 11.
2
Assessing the Efficacy of Mitochondria-Accumulating Self-Assembly Peptides in Pancreatic Cancer: An Animal Study.评估线粒体聚集自组装肽在胰腺癌中的疗效：一项动物研究。
Int J Mol Sci. 2025 Jan 17;26(2):784. doi: 10.3390/ijms26020784.
3
Simmons-Smith Cyclopropanation: A Multifaceted Synthetic Protocol toward the Synthesis of Natural Products and Drugs: A Review.西蒙斯-史密斯环丙烷化反应：一种多方面的合成方法，用于合成天然产物和药物：综述。
Molecules. 2023 Jul 26;28(15):5651. doi: 10.3390/molecules28155651.
4
Visible and NIR light photoactivatable -hydroxycinnamate system for efficient drug release with fluorescence monitoring.用于通过荧光监测实现高效药物释放的可见光和近红外光光可激活羟基肉桂酸酯系统。
RSC Med Chem. 2023 Mar 1;14(6):1088-1100. doi: 10.1039/d2md00438k. eCollection 2023 Jun 22.
5
Synthesis of Veliparib Prodrugs and Determination of Drug-Release-Dependent PARP-1 Inhibition.维利帕尼前药的合成及药物释放依赖性PARP-1抑制作用的测定
ACS Med Chem Lett. 2023 Apr 24;14(5):652-657. doi: 10.1021/acsmedchemlett.3c00065. eCollection 2023 May 11.
6
Beyond the TPP "gold standard": a new generation mitochondrial delivery vector based on extended PN frameworks.超越TPP“金标准”：基于扩展PN框架的新一代线粒体递送载体。
Chem Sci. 2023 Feb 13;14(15):4126-4133. doi: 10.1039/d2sc06508h. eCollection 2023 Apr 12.
7
Environmental Chemical Exposures and Mitochondrial Dysfunction: a Review of Recent Literature.环境化学暴露与线粒体功能障碍：最新文献综述。
Curr Environ Health Rep. 2022 Dec;9(4):631-649. doi: 10.1007/s40572-022-00371-7. Epub 2022 Jul 28.
8
A campaign targeting a conserved Hsp70 binding site uncovers how subcellular localization is linked to distinct biological activities.靶向保守的 Hsp70 结合位点的研究揭示了亚细胞定位与不同生物学活性之间的关系。
Cell Chem Biol. 2022 Aug 18;29(8):1303-1316.e3. doi: 10.1016/j.chembiol.2022.06.006. Epub 2022 Jul 12.
9
Sindbis Virus Replication Reduces Dependence on Mitochondrial Metabolism During Infection.辛德毕斯病毒复制减少了感染过程中对线粒体代谢的依赖。
Front Cell Infect Microbiol. 2022 Jun 16;12:859814. doi: 10.3389/fcimb.2022.859814. eCollection 2022.
10
Mitochondria-targeted senotherapeutic interventions.线粒体靶向衰老治疗干预。
Biogerontology. 2022 Aug;23(4):401-423. doi: 10.1007/s10522-022-09973-y. Epub 2022 Jul 4.
本文引用的文献
1
Mitochondrial reactive oxygen species regulate hypoxic signaling.线粒体活性氧调节低氧信号转导。
Curr Opin Cell Biol. 2009 Dec;21(6):894-9. doi: 10.1016/j.ceb.2009.08.005. Epub 2009 Sep 24.
2
The mitochondria-targeted nitroxide JP4-039 augments potentially lethal irradiation damage repair.线粒体靶向性氮氧化物JP4-039增强潜在致死性辐射损伤修复。
In Vivo. 2009 Sep-Oct;23(5):717-26.
3
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.辅酶Q10用于肌萎缩侧索硬化症的II期试验发现，没有足够证据支持开展III期试验。
Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743.
4
Cancer: The fat and the furious.癌症：脂肪与危害。
Nature. 2009 Sep 3;461(7260):44-5. doi: 10.1038/461044a.
5
Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions.线粒体靶向电子清除抗氧化剂：选择性氧化与随机链反应的调节。
Adv Drug Deliv Rev. 2009 Nov 30;61(14):1375-85. doi: 10.1016/j.addr.2009.06.008. Epub 2009 Aug 27.
6
The changing shape of mitochondrial apoptosis.线粒体凋亡形态的变化
Trends Endocrinol Metab. 2009 Aug;20(6):287-94. doi: 10.1016/j.tem.2009.03.007. Epub 2009 Jul 31.
7
Targeting mitochondria with organelle-specific compounds: strategies and applications.利用细胞器特异性化合物靶向线粒体：策略与应用
Chembiochem. 2009 Aug 17;10(12):1939-50. doi: 10.1002/cbic.200900185.
8
Is the oxidative stress theory of aging dead?衰老的氧化应激理论已被否定了吗？
Biochim Biophys Acta. 2009 Oct;1790(10):1005-14. doi: 10.1016/j.bbagen.2009.06.003. Epub 2009 Jun 11.
9
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?通过活性氧介导的机制靶向癌细胞：一种激进的治疗方法？
Nat Rev Drug Discov. 2009 Jul;8(7):579-91. doi: 10.1038/nrd2803. Epub 2009 May 29.
10
Regulation and pharmacology of the mitochondrial permeability transition pore.线粒体通透性转换孔的调控与药理学
Cardiovasc Res. 2009 Jul 15;83(2):213-25. doi: 10.1093/cvr/cvp151. Epub 2009 May 15.
Zotero 插件